These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8258847)

  • 1. Mutagenic and clastogenic properties of (3-[3-(6-benzoyloxy-3-cyano-2- pyridyloxycarbonyl) benzoyl]-1-ethoxymethyl-5-fluorouracil) (BOF-A2), a new 5-fluorouracil derivative with anti-tumour activity.
    Shibahara T; Kaneko E; Itoh T; Awogi T; Tsushimoto G; Takahashi N; Marshall RR; Kirkland DJ
    J Toxicol Sci; 1993 Aug; 18 Suppl 3():11-9. PubMed ID: 8258847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of BOF-A2, a new 5-fluorouracil derivative.
    Fujii S; Fukushima M; Shimamoto Y; Ohshimo H; Imaoka T; Shirasaka T
    Jpn J Cancer Res; 1989 Feb; 80(2):173-81. PubMed ID: 2498252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic characteristics and antitumor activity of BOF-A2, a new 5-fluorouracil derivative].
    Shirasaka T; Fukushima M; Shimamoto Y; Kimura Y; Ohshimo H; Imaoka T; Kimura A; Utsunomiya T; Fujii S
    Gan To Kagaku Ryoho; 1990 May; 17(5):1051-8. PubMed ID: 2334171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity tests of 4-phenyl-1,3-dithia-2-thioxo-cyclopent-4-ene.
    Sadanobu S; Holmstrom ML; Riach CG; Leddy IA; Tezuka M
    J Toxicol Sci; 1999 May; 24(2):87-94. PubMed ID: 10349610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo genotoxicity tests on fullerene C60 nanoparticles.
    Shinohara N; Matsumoto K; Endoh S; Maru J; Nakanishi J
    Toxicol Lett; 2009 Dec; 191(2-3):289-96. PubMed ID: 19772904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxicity evaluation of Hwanglyeonhaedok-tang, an herbal formula.
    Jin SE; Lee MY; Seo CS; Ha H; Kim JY; Shin HK
    J Ethnopharmacol; 2017 Apr; 202():122-126. PubMed ID: 27916588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxicity assessment of pirmenol, a new antiarrhythmic drug.
    Ciaravino V; Kropko ML; Krishna G; Monteith DK; Theiss JC
    Mutat Res; 1992; 280(3):205-14. PubMed ID: 1381484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity assessment of two hypergolic energetic propellant compounds.
    Reddy G; Song J; Mecchi MS; Johnson MS
    Mutat Res; 2010 Jul; 700(1-2):26-31. PubMed ID: 20417306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc].
    Shibata K; Matsuda K; Ohta T; Sasaki Y; Sutou S
    Arzneimittelforschung; 1991 Oct; 41(10):1053-7. PubMed ID: 1799383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity of the new quinolone antibacterial agent levofloxacin.
    Shimada H; Itoh S; Hattori C; Tada S; Matsuura Y
    Arzneimittelforschung; 1992 Mar; 43(3A):378-85. PubMed ID: 1622436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity assessment of ethylenediamine dinitrate (EDDN) and diethylenetriamine trinitrate (DETN).
    Reddy G; Song J; Kirby P; Johnson MS
    Mutat Res; 2011 Dec; 726(2):169-74. PubMed ID: 21944905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of genetic toxicity of 6-diazo-5-oxo-l-norleucine (DON).
    Kulkarni RM; Dakoulas EW; Miller KE; Terse PS
    Toxicol Mech Methods; 2017 Sep; 27(7):518-527. PubMed ID: 28552037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genotoxicity of an aqueous extract of Gyejibokryeong-hwan.
    Lee MY; Seo CS; Ha H; Park E; Kim JY; Shin HK
    BMC Complement Altern Med; 2018 Jan; 18(1):21. PubMed ID: 29357857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity testing of pidotimod in vitro and in vivo.
    Adams K; Allen JA; Brooker PC; Henderson L; Jones E; Proudlock RJ; Mailland F; Coppi G
    Arzneimittelforschung; 1994 Dec; 44(12A):1454-9. PubMed ID: 7857341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of mutagenic effects of sodium dichloroacetate.
    Fox AW; Yang X; Murli H; Lawlor TE; Cifone MA; Reno FE
    Fundam Appl Toxicol; 1996 Jul; 32(1):87-95. PubMed ID: 8812237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-phase dependent cytogenetic toxicity of 5-fluorouracil in bone marrow cells of mice.
    Choudhury RC; Misra S; Jagdale MB; Palo AK
    J Exp Clin Cancer Res; 2001 Mar; 20(1):57-62. PubMed ID: 11370831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of the genotoxicity of 2-hydroxy-1,4-naphthoquinone, the natural dye ingredient of Henna.
    Kirkland D; Marzin D
    Mutat Res; 2003 Jun; 537(2):183-99. PubMed ID: 12787822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A mutagenicity study of calcipotriol (MC903)].
    Kitagaki T; Oguma Y; Yokota F; Ono M; Shirakawa K; Nagata M; Konishi R
    J Toxicol Sci; 1996 Jul; 21 Suppl 2():465-74. PubMed ID: 8741426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutagenicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
    Ohuchida A; Kouchi Y; Sato S; Maeda Y
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():675-89. PubMed ID: 9021668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of chemopreventive agents for genotoxic activity.
    Doppalapudi RS; Riccio ES; Rausch LL; Shimon JA; Lee PS; Mortelmans KE; Kapetanovic IM; Crowell JA; Mirsalis JC
    Mutat Res; 2007 May; 629(2):148-60. PubMed ID: 17387038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.